Literature DB >> 4729921

Phytohaemagglutinin-induced lymphocyte transformation in patients before and after resection of large intestinal cancer.

M B McIllmurray, M Gray, M J Langman.   

Abstract

Lymphocyte responses to stimulation with phytohaemagglutinin (PHA) have been compared in 20 patients with large intestinal cancer, 10 patients whose large intestinal cancers have been removed, and in 30 age- and sex-matched control individuals. Responses were markedly reduced in the tumour-bearing patients and were unaffected by substituting normal for autologous plasma during incubation. Responses, however, were normal after tumour resection suggesting that the defect in lymphocyte responsiveness is a reversible one and related to the presence of tumour tissue.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4729921      PMCID: PMC1412795          DOI: 10.1136/gut.14.7.541

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  16 in total

1.  The delayed type of allergic reaction in cancer: altered response to tuberculin and mumps virus.

Authors:  J LOGAN
Journal:  N Z Med J       Date:  1956-10

2.  Hodgkin's disease and immunity.

Authors:  W W SCHIER; A ROTH; G OSTROFF; M H SCHRIFT
Journal:  Am J Med       Date:  1956-01       Impact factor: 4.965

3.  Lymphocyte transformation in cancer patients.

Authors:  C Hagen; A Froland; E Weberg
Journal:  Lancet       Date:  1972-06-17       Impact factor: 79.321

4.  Cellular and humoral immunity to different types of human neoplasms.

Authors:  I Hellström; K E Hellström; G E Pierce; J P Yang
Journal:  Nature       Date:  1968-12-28       Impact factor: 49.962

5.  Lymphocyte response to P.H.A. in patients with non-lymphoid tumours.

Authors:  D B Garrioch; R A Good; R A Gatti
Journal:  Lancet       Date:  1970-03-21       Impact factor: 79.321

6.  Effect of serum from cancer patients on homologous lymphocyte cultures.

Authors:  E K Golob; T Israsena; A C Quatrale; K L Becker
Journal:  Cancer       Date:  1969-02       Impact factor: 6.860

7.  Suppression of the tuberculin response in malignant disease.

Authors:  L E Hughes; W D Mackay
Journal:  Br Med J       Date:  1965-12-04

8.  Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary, and bronchial carcinoma.

Authors:  D J Laurence; U Stevens; R Bettelheim; D Darcy; C Leese; C Turberville; P Alexander; E W Johns; A M Neville
Journal:  Br Med J       Date:  1972-09-09

9.  DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.

Authors:  P GOLD; S O FREEDMAN
Journal:  J Exp Med       Date:  1965-03-01       Impact factor: 14.307

10.  Specific carcinoembryonic antigens of the human digestive system.

Authors:  P Gold; S O Freedman
Journal:  J Exp Med       Date:  1965-09-01       Impact factor: 14.307

View more
  5 in total

1.  Frontiers in inflammatory bowel disease. The proceedings of a conference sponsored by the McReynolds Foundation. Part II.

Authors:  R G Shorter; D A Shephard
Journal:  Am J Dig Dis       Date:  1975-07

Review 2.  Tumour immunology and the gut.

Authors:  K C Calman
Journal:  Gut       Date:  1975-06       Impact factor: 23.059

3.  Study of nonspecific lymphocyte transformation in urologic cancer patients.

Authors:  I Romics; J Horváth
Journal:  Int Urol Nephrol       Date:  1978       Impact factor: 2.370

4.  The investigation of cellular and humoral immune reactivity in patients with tumours of the bladder.

Authors:  I Romics; J Fehér; J Horváth; L Kisbenedek; F Balogh
Journal:  Int Urol Nephrol       Date:  1982       Impact factor: 2.370

5.  Inhibition of leucocyte migration in patients with large intestinal cancer by extracts prepared from large intestinal tumours and from normal colonic mucosa.

Authors:  M B McIllmurray; M R Price; M J Langman
Journal:  Br J Cancer       Date:  1974-04       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.